全国首个“中医脑机接口”装备落地，医疗创新ETF(516820)持续获资金关注

Group 1 - The core viewpoint of the news highlights the performance of the China Securities Pharmaceutical and Medical Device Innovation Index, with notable stocks like Dong'e Ejiao leading the gains at 3.35% [1] - The Medical Innovation ETF has seen continuous net inflows over the past 13 days, with a maximum single-day net inflow of 41.83 million yuan, totaling 246 million yuan, averaging 18.91 million yuan per day [1] - The first brain-controlled acupuncture and neuro-rehabilitation equipment platform, "Shengong-Hua Tuo," has been developed by a collaborative team, showcasing innovative technology that integrates brain-machine interfaces with smart wearable acupuncture [1] Group 2 - Huajin Securities notes that the National Medical Products Administration has prioritized "artificial intelligence medical devices" as one of four key development areas, indicating a strong policy push [2] - The global AI medical market is projected to grow at a CAGR of 35.5% from 2022 to 2030, reaching 155.3 billion USD by 2030 [2] - The China Securities Pharmaceutical and Medical Device Innovation Index comprises 30 publicly listed companies with strong profitability and growth potential, reflecting the overall performance of the pharmaceutical and medical device sector [2] - As of January 30, 2026, the top ten weighted stocks in the index account for 63.9% of the total index, including companies like WuXi AppTec and Mindray Medical [2]